|
Jul 31
|
Sales of Leqembi® totaled 23.1 billion yen in the second quarter 2025
|
|
Jul 31
|
BioArtic: Latest data presented at AAIC 2025 reinforces lecanemab's clinical effect with consistent safety profile
|
|
Jul 22
|
Lecanemab four-year efficacy and safety data to be presented at AAIC 2025
|
|
Jun 2
|
BioArctic's Capital Markets Day 2025 - entering a new era of growth
|
|
Oct 14
|
Spotlighting 3 Swedish Growth Stocks With Strong Insider Ownership
|
|
Oct 8
|
3 High Growth Swedish Tech Stocks To Watch
|
|
Oct 8
|
Top Swedish Growth Companies With High Insider Ownership In October 2024
|
|
Aug 30
|
Swedish Growth Companies With High Insider Ownership August 2024
|
|
Aug 30
|
Top Swedish Growth Stocks With High Insider Ownership
|
|
Jul 25
|
Swedish Growth Companies With High Insider Ownership And 31% ROE
|
|
Jul 25
|
Swedish Growth Companies With High Insider Ownership In July 2024
|